• Mostafa.Hamed@helmholtz-hips.de
• +4968198806-2022

of Drug Design and Optimization (DDOP). He is a medicinal chemist whose research focuses on the development of novel anti-infective and antivirulence agents, and has contributed to multiple drug discovery

• ayanda.zulu@helmholtz-hips.de
• +49 68198806-2051

PhD in Chemistry from Rhodes University in South Africa. After graduation in 2021, she joined the Drug Discovery and Development center (H3D) as postdoctoral research fellow. During her time at H3D, her [...] molecules as antimalarial or…

• soeren.klein@helmholtz-hips.de
• +49 681 98806 2113

year later in Prof. Martin Empting's “Anti-Infective Drug Discovery” research group. His research focuses on the synthesis and optimization of new drug candidates for the novel anti-tumor and diabetes target

• walid.mohammad@helmholtz-hips.de
• +4968198806-2013

focuses on the application of modern drug design approaches tackling un(der)exploited therapeutic targets and the use of biophysical and computational techniques for drug discovery and optimization.

• Joerg.Haupenthal@helmholtz-hips.de
• +49-681-98806-2011

is a senior scientist (biologist) in the research department Drug Design and Optimisation at HIPS. After researching novel anti-cancer drugs for several years, he started focusing on the development of